NG-TEST® MCR-1
Results within 15 minutes
NG-TEST® MCR-1 is a qualitative lateral flow immunoassay for the rapid detection of Colistin resistance, in less than 15 minutes.
It detects plasmid-mediated colistin resistance in Gram-negative bacteria directly from a bacterial colony by identifying the MCR-1 enzyme.
Sensitivity: 100% – Specificity: 98.4%
Specification and Support documents
AMR diagnostic brochure
MSDS - NG-TEST® MCR-1
| Product Name | Targets | Description | Technology | Reference |
|---|---|---|---|---|
| NG-TEST® MCR-1 | MCR-1 | 20 cassettes, buffer, 20 microtubes, 20 pipettes | Lateral flow | NGB-MCR-S23-016 |
Bibliography
Over the past several years, numerous scientific studies have been conducted and peer-reviewed supporting the exciting capabilities of our rapid tests.
Please take a moment to complete the following information and you will receive the publications via email.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labelling for instructions for use, warnings, and limitations specific to each product and region.
ULTRA-FAST RESULTS
15 min from colony
EASY TO USE
1 min Hands-on time and no training required
RELIABLE & HIGH PERFORMANCE
Clinically validated (CE marked)
EQUIPMENT FREE
No maintenance or hidden costs
Streamlined Workflow – Save time to enable better management of sepsis
Clinical Guidance – Support clinicians in their medical decisions
Stewardship – Optimize antibiotic use and patient management
Cost-Efficient – Reduces unnecessary therapy
WORKFLOW
NG-TEST® MCR-1 is a qualitative rapid immunoassay for the detection of the MCR-1 enzyme in a bacterial colony obtained from culture. It is an in vitro diagnostic assay, for professional use only, that aids in the rapid identification of antibiotic-resistant bacteria.
The use of NG-TEST® MCR-1 in the laboratory provides information to inform appropriate antimicrobial therapeutic choices and support prompt infection control decision making and interventions.
NG-TEST® MCR-1 can be easily implemented into any laboratory settings with minimal training. It requires minimal hands-on time, the preparation protocol is simple and no instrumentation is required.
Due to the increase in the percentage of infections caused by Multi-Drug Resistant (MDR) bacteria, more information is needed about the expressed mechanisms of resistance to help guide the optimal antibiotic treatment and to manage infected patients appropriately.
At NG Biotech we continuously develop complementary products to provide clinicians will additional clinically relevant information to adequately treat patients.
